AU2003225191A8 - Methods useful in treatment and prevention of hiv infection - Google Patents

Methods useful in treatment and prevention of hiv infection

Info

Publication number
AU2003225191A8
AU2003225191A8 AU2003225191A AU2003225191A AU2003225191A8 AU 2003225191 A8 AU2003225191 A8 AU 2003225191A8 AU 2003225191 A AU2003225191 A AU 2003225191A AU 2003225191 A AU2003225191 A AU 2003225191A AU 2003225191 A8 AU2003225191 A8 AU 2003225191A8
Authority
AU
Australia
Prior art keywords
prevention
treatment
hiv infection
methods useful
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003225191A
Other versions
AU2003225191A1 (en
Inventor
Fernando Arenzana-Seisdedos
Jean-Jacques Pin
Sem Saeland
Ali Amara
Serge J E Lebecque
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2003225191A8 publication Critical patent/AU2003225191A8/en
Publication of AU2003225191A1 publication Critical patent/AU2003225191A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003225191A 2002-05-02 2003-04-30 Methods useful in treatment and prevention of hiv infection Abandoned AU2003225191A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37745902P 2002-05-02 2002-05-02
US60/377,459 2002-05-02
PCT/US2003/013163 WO2003093415A2 (en) 2002-05-02 2003-04-30 Methods useful in treatment and prevention of hiv infection

Publications (2)

Publication Number Publication Date
AU2003225191A8 true AU2003225191A8 (en) 2003-11-17
AU2003225191A1 AU2003225191A1 (en) 2003-11-17

Family

ID=29401501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003225191A Abandoned AU2003225191A1 (en) 2002-05-02 2003-04-30 Methods useful in treatment and prevention of hiv infection

Country Status (2)

Country Link
AU (1) AU2003225191A1 (en)
WO (1) WO2003093415A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019140147A1 (en) * 2018-01-12 2019-07-18 The Wistar Institute Of Anatomy And Biology Methods for identifying and treating hiv persistence

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997476A3 (en) * 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses

Also Published As

Publication number Publication date
WO2003093415A3 (en) 2004-02-26
WO2003093415A2 (en) 2003-11-13
AU2003225191A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
AU2003290548A8 (en) Prevention and treatment of synucleinopathic disease
ZA200505272B (en) Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
EP1689348A4 (en) Oligosaccharide compositions and use thereof in the treatment of infection
IL180947A0 (en) Vaccine for prevention and treatment of hiv infection
IL174796A0 (en) Methods for treating viral infection using-il-28 and il-29
EP1753777A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5a
AU2003260527A8 (en) Methods of positions and/or orienting nanostructures
EP1545429A4 (en) Methods and compositions for treatment of dermal conditions
HK1068885A1 (en) N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases n--
AU2003291342A1 (en) Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
HK1088225A1 (en) Compositions comprising immunomodulatory compoundsfor treatment, modification and management of pai n
AU2002359512A8 (en) Belts and methods of use thereof
AU2003209851A1 (en) Method of treatment and/or prophylaxis
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
HK1151294A1 (en) Oligonucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome
AU2003274963A8 (en) Mda-7 and free radicals in the treatment of cancer
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
AU2003217604A8 (en) Method of treating hiv infection by preventing interaction of cd4 and gp120
EP1569723A4 (en) Nucleotide based medicament and method of use for treatment of conditions in humans
EP1696918A4 (en) A method of treating hiv infection in atazanavir resistant patients using a combination of atazanavir and another protease inhibitor
AU2003225191A8 (en) Methods useful in treatment and prevention of hiv infection
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
GB0300078D0 (en) Composition for the treatment of HIV and AIDS
EP1463741A4 (en) Compounds to treat hiv infection and aids
GB0205395D0 (en) Materials and methods relating to the treatment of lymphoma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase